Pembrolizumab and the significance of PD-L1 for lung cancer VJOncology 0:56 7 years ago 576 Скачать Далее
Pembrolizumab as Second-line Therapy for Advanced Urothelial Carcinoma NEJM Group 2:05 7 years ago 9 313 Скачать Далее
Dr. Herbst on Long Term Survival With Pembrolizumab in NSCLC OncLive 1:14 5 years ago 1 443 Скачать Далее
How pembrolizumab will change the management of advanced lung cancer VJOncology 0:57 7 years ago 537 Скачать Далее
Is pembrolizumab alone sufficient to treat bladder cancer? VJOncology 3:51 6 years ago 1 004 Скачать Далее
KEYNOTE-826: Pembrolizumab plus chemotherapy for patients with metastatic cervical cancer VJOncology 2:26 2 years ago 1 067 Скачать Далее
ESMO 2020 Highlights on pembrolizumab as 1st line therapy for aUC: The KEYNOTE-361 study European Society for Medical Oncology (ESMO) 3:21 3 years ago 2 381 Скачать Далее
Pembrolizumab, Tumor Response, and Survival in Advanced Melanoma JAMA Network 3:03 8 years ago 3 287 Скачать Далее
Adjuvant pembrolizumab improves RCC disease-free survival | Toni Choueiri Medicine Matters oncology 3:03 3 years ago 1 209 Скачать Далее
Adjuvant Pembrolizumab and Survival in Renal-Cell Carcinoma | NEJM NEJM Group 2:22 3 months ago 1 154 Скачать Далее
Antibiotics impact outcomes with pembrolizumab in NSCLC patients VJOncology 2:03 3 years ago 241 Скачать Далее
Pembrolizumab monotherapy for older/ABVD-ineligible patients with Hodgkin lymphoma VJHemOnc – Video Journal of Hematology & HemOnc 4:18 11 months ago 334 Скачать Далее
KEYNOTE-355: pembrolizumab in triple-negative breast cancer VJOncology 2:07 4 years ago 2 872 Скачать Далее
Concurrent pembrolizumab and chemotherapy in classical Hodgkin lymphoma VJHemOnc – Video Journal of Hematology & HemOnc 1:28 2 years ago 167 Скачать Далее
Pembrolizumab demonstrates improvement in distant metastasis-free survival in patients with melanoma ecancer 2:31 2 years ago 508 Скачать Далее